13F HOLDINGS REPORT
BROADWOOD CAPITAL INC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0000919574-23-004614
Total Value
$1.34B
Positions
7
Other Managers
1
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MONSTER BEVERAGE CORP NEW | MNST | 9,312,976 | $534.9M | 39.99% |
| 2 | STAAR SURGICAL CO | STAA | 8,783,082 | $461.7M | 34.52% |
| 3 | AXON ENTERPRISE INC | AXON | 760,062 | $148.3M | 11.09% |
| 4 | ISHARES TR | 464287655 | 690,000 | $129.2M | 9.66% |
| 5 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 34,935,485 | $49.3M | 3.68% |
| 6 | ONCOCYTE CORP | 68235C107 | 50,181,335 | $11.5M | 0.86% |
| 7 | AGEX THERAPEUTICS INC | 00848H108 | 2,997,156 | $2.7M | 0.20% |